Spruce Biosciences (SPRB) Equity Ratio (2022 - 2025)
Spruce Biosciences (SPRB) has disclosed Equity Ratio for 4 consecutive years, with 0.8 as the latest value for Q4 2025.
- On a quarterly basis, Equity Ratio rose 25.78% to 0.8 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.8, a 25.78% increase, with the full-year FY2025 number at 0.8, up 25.78% from a year prior.
- Equity Ratio was 0.8 for Q4 2025 at Spruce Biosciences, up from 0.35 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.87 in Q1 2022 to a low of 0.35 in Q3 2025.
- A 4-year average of 0.72 and a median of 0.77 in 2023 define the central range for Equity Ratio.
- Biggest YoY gain for Equity Ratio was 25.78% in 2025; the steepest drop was 55.66% in 2025.
- Spruce Biosciences' Equity Ratio stood at 0.8 in 2022, then fell by 7.95% to 0.74 in 2023, then fell by 13.39% to 0.64 in 2024, then grew by 25.78% to 0.8 in 2025.
- Per Business Quant, the three most recent readings for SPRB's Equity Ratio are 0.8 (Q4 2025), 0.35 (Q3 2025), and 0.6 (Q2 2025).